JFL Life Sciences Ltd.

View in App
42.60 0.00

08 June 2023, 03:59:56 PM
Volume: 0

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.jfllifesciences.com
Market Cap 46.85 Cr.
Enterprise Value(EV) 54.03 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 2.55 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 16.67 Trailing Twelve Months Ending 2023-03
Industry PE 33.65 Trailing Twelve Months Ending 2023-03
Book Value / Share 29.61 Trailing Twelve Months Ending 2023-03
Price to Book Value 1.44 Calculated using Price: 42.60
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 1.10 Cr. 10,998,441 Shares
FaceValue 10
About JFL Life Sciences Ltd.
JFL Life Sciences manufactures a wide range of pharmaceutical formulations. The company’s major products types are Dry powder injections; Tablets & Capsules (B-Lactam) solid oral dosage form; Tablet and capsules (General); and Oral Rehydration Solutions (ORS).

JFL Life Sciences Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

JFL Life Sciences Ltd. Performance

View details >>
1 Day
1 Week
+12.11%
1 Month
-8.39%
3 Month
+23.48%
6 Month
+16.71%
1 Year
2 Year
5 Year
10 Year

JFL Life Sciences Ltd. Fundamental Ratios

View details >>
3 years 2019-03 2020-03 2021-03
Return on Equity (%) 6.03 6.94 8.85
Return on Capital Employed (%) 8.71 11.80 10.32
Return on Assets (%) 1.87 1.78 2.03

JFL Life Sciences Ltd. Balance Sheet

View details >>
Particulars 5 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 5 5 7 11 32
Non Curr. Liab. 3 1 8 9 2
Curr. Liab. 8 18 14 28 15
Minority Int.
Equity & Liab. 16 24 29 48 49
Non Curr. Assets 3 6 9 9 8
Curr. Assets 14 18 20 39 41
Misc. Exp. not W/O
Total Assets 16 24 29 48 49

JFL Life Sciences Ltd. Profit and Loss

View details >>
Particulars 3 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Net Sales 32 30 33
Other Income 0 0
Total Income 32 30 33
Total Expenditure -30 -28 -31
PBIDT 1 2 2
Interest -1 -1 -1
Depreciation 0 0 0
Taxation 0 0 0
Exceptional Items
PAT 0 0 1
Adjusted EPS 1 1 1

JFL Life Sciences Ltd. Cash Flow

View details >>
Particulars 3 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. -3 3 -6
Cash Fr. Inv. -1 -3 -2
Cash Fr. Finan. 4 0 7
Net Change 0 0
Cash & Cash Eqvt 0 0 0

JFL Life Sciences Ltd. Shareholding Pattern

View details >>
3 Qtrs 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 67.47 67.47 67.47
Public 32.53 32.53 32.54
Depository Receipts 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00

JFL Life Sciences Ltd. Announcements

View details >>

No Corporate Announcement found.

JFL Life Sciences Ltd. Technical Scans

View details >>
Wed, 07 Jun 2023
High Delivery Percentage High Delivery Percentage
Opening at Low Opening at Low
Opening at Low for 3 days Opening at Low for 3 days
Closing Above Previous High Closing Above Previous High
S Opening at Low for 2 Days

JFL Life Sciences Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 236,838.35 987.10 -2.7%
Divi's Laboratories Ltd. 92,904.71 3,499.65 -1.2%
Cipla Ltd. 77,933.48 965.45 +0.5%
Dr. Reddy's Laboratories Ltd. 77,441.55 4,649.90 -0.5%
Apollo Hospitals Enterprise Ltd. 70,842.70 4,927.00 -2.0%
Torrent Pharmaceuticals Ltd. 60,989.56 1,802.05 +0.0%
Mankind Pharma Ltd. 58,646.15 1,464.00 -1.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 27.95 987.10 -2.7%
Divi's Laboratories Ltd. Consolidated 2023-03 50.95 3,499.65 -1.2%
Cipla Ltd. Consolidated 2023-03 27.81 965.45 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 17.18 4,649.90 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 86.49 4,927.00 -2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 48.99 1,802.05 +0.0%
Mankind Pharma Ltd. Consolidated 2023-03 45.75 1,464.00 -1.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.23 987.10 -2.7%
Divi's Laboratories Ltd. Consolidated 2023-03 7.28 3,499.65 -1.2%
Cipla Ltd. Consolidated 2023-03 3.33 965.45 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.33 4,649.90 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.45 4,927.00 -2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.84 1,802.05 +0.0%
Mankind Pharma Ltd. Consolidated 2023-03 4.99 1,464.00 -1.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 987.10 -2.7%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,499.65 -1.2%
Cipla Ltd. Consolidated 2022-03 0.04 965.45 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,649.90 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,927.00 -2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,802.05 +0.0%
Mankind Pharma Ltd. Consolidated 2022-03 0.14 1,464.00 -1.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 987.10 -2.7%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,499.65 -1.2%
Cipla Ltd. Consolidated 2022-03 13.10 965.45 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,649.90 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,927.00 -2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,802.05 +0.0%
Mankind Pharma Ltd. Consolidated 2022-03 26.72 1,464.00 -1.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 987.10 -2.7%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,499.65 -1.2%
Cipla Ltd. Consolidated 2022-03 13.10 965.45 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,649.90 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,927.00 -2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,802.05 +0.0%
Mankind Pharma Ltd. Consolidated 2022-03 26.72 1,464.00 -1.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 987.10 -2.7%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,499.65 -1.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 965.45 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,649.90 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,927.00 -2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,802.05 +0.0%
Mankind Pharma Ltd. Consolidated 2022-03 7,781.56 1,464.00 -1.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 987.10 -2.7%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,499.65 -1.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 965.45 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,649.90 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,927.00 -2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,802.05 +0.0%
Mankind Pharma Ltd. Consolidated 2022-03 1,452.96 1,464.00 -1.5%

JFL Life Sciences Ltd. FAQ's

What is JFL Life Sciences share price?
Can I buy JFL Life Sciences shares now?
What is the Market Cap of JFL Life Sciences?
What are the key metrics to analyse JFL Life Sciences?
What is the trend of JFL Life Sciences share price?